Filing Details
- Accession Number:
- 0001127602-24-003582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-06 16:43:54
- Reporting Period:
- 2024-02-06
- Accepted Time:
- 2024-02-06 16:43:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551778 | Ibraham Fady Malik | 350 Oyster Point Blvd South San Francisco CA 94080 | Evp Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-06 | 28,605 | $6.67 | 175,578 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-02-06 | 28,605 | $79.30 | 146,973 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-06 | 4,000 | $79.28 | 142,973 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2024-02-06 | 28,605 | $0.00 | 28,605 | $6.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
57,209 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.